Re: Retention AgreementRetention Agreement • March 1st, 2021 • Viatris Inc • Pharmaceutical preparations • Pennsylvania
Contract Type FiledMarch 1st, 2021 Company Industry JurisdictionAs you know, Mylan N.V. (“Mylan”) and Upjohn Inc. (“Upjohn”) consummated the combination of Mylan and Upjohn pursuant to the Business Combination Agreement between Pfizer Inc., Upjohn, Mylan and the other parties thereto to create Viatris Inc. (the “Company”), a new champion for global health, on November 16, 2020. In recognition of your efforts in connection with the consummation of the combination (the “Closing”), and in order to incentivize you to remain employed with the Company and its affiliates, the Company hereby grants you the following retention bonus opportunity.
Re: Retention AgreementRetention Agreement • March 1st, 2021 • Viatris Inc • Pharmaceutical preparations • Pennsylvania
Contract Type FiledMarch 1st, 2021 Company Industry JurisdictionAs you know, Mylan N.V. (“Mylan”) and Upjohn Inc. (“Upjohn”) consummated the combination of Mylan and Upjohn pursuant to the Business Combination Agreement between Pfizer Inc., Upjohn, Mylan and the other parties thereto to create Viatris Inc. (the “Company”), a new champion for global health, on November 16, 2020. In recognition of your efforts in connection with the consummation of the combination (the “Closing”), and in order to incentivize you to remain employed with the Company and its affiliates, the Company hereby grants you the following retention bonus opportunity.